13D Filing: SC Fundamental Value Fund, L.P. and Aviragen Therapeutics Inc. (AVIR)

Page 12 of 12

Page 12 of 12 – SEC Filing

SCHEDULE A

 

Identity of Person Effecting the Transaction Date of Transaction Number of Shares Sold Price Per Share
SC Fundamental Value Fund, L.P. 01/12/2018 380,000 $0.6850
SC Fundamental Value Fund, L.P. 01/16/2018 181,721 $0.7000

  

These transactions were all
open-market transactions. 

Follow Vaxart Inc. (NASDAQ:VXRT)

Page 12 of 12